Developing and adopting safe and effective digital biomarkers to improve patient outcomes

By Andrea Coravos, S. Khozin, Kenneth D. Mandl. npj Digital Medicine, 2019

304 citations recorded by the source corpus.

Biomarkers are physiologic, pathologic, or anatomic characteristics that are objectively measured and evaluated as an indicator of normal biologic processes, pathologic processes, or biological responses to therapeutic interventions. Recent advances in the development of mobile digitally connected technologies have led to the emergence of a new class of biomarkers measured across multiple layers of hardware and software. Quantified in ones and zeros, these “digital” biomarkers can support continuous measurements outside the physical confines of the clinical environment. The modular software–hardware combination of these products has created new opportunities for patient care and biomedical research, enabling remote monitoring and decentralized clinical trial designs. However, a systematic approach to assessing the quality and utility of digital biomarkers to ensure an appropriate balance between their safety and effectiveness is needed. This paper outlines key considerations for the development and evaluation of digital biomarkers, examining their role in clinical research and routine patient care.

Subfields: Biomedical Engineering

View Paper: https://www.semanticscholar.org/paper/90fcfcfee3d1bdc0eed15ae7bff4a689361345b0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. D. Weeraratne
  2. Kevin B. Johnson
  3. M. Frisse
  4. Wei-Qi Wei
  5. Juan Zhao
  6. J. Snowdon
  7. K. Rhee
  8. K. Misulis

Citations in the corpus